Signaturefd LLC Sells 2,419 Shares of Agilent Technologies, Inc. $A

Key Points

• Signaturefd LLC reduced its stake in Agilent Technologies by 35.4%, selling 2,419 shares during the second quarter, and now holds 4,405 shares valued at approximately $520,000.
• Agilent Technologies reported a quarterly earnings per share (EPS) of $1.37, matching analysts' expectations, and achieved revenue of $1.74 billion, exceeding the forecast of $1.67 billion.
• The company announced a quarterly dividend of $0.248 per share, representing an annual yield of 0.8%, with the ex-dividend date set for September 30th.

Signaturefd LLC cut its stake in Agilent Technologies, Inc. (NYSE:A - Free Report) by 35.4% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 4,405 shares of the medical research company's stock after selling 2,419 shares during the quarter. Signaturefd LLC's holdings in Agilent Technologies were worth $520,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. First American Bank bought a new stake in Agilent Technologies during the second quarter valued at approximately $548,000. Patton Fund Management Inc. bought a new position in Agilent Technologies in the 2nd quarter worth $244,000. Novem Group lifted its position in Agilent Technologies by 4.1% during the second quarter. Novem Group now owns 8,381 shares of the medical research company's stock valued at $989,000 after purchasing an additional 328 shares in the last quarter. Cardinal Capital Management lifted its position in Agilent Technologies by 4.6% during the second quarter. Cardinal Capital Management now owns 73,561 shares of the medical research company's stock valued at $8,681,000 after purchasing an additional 3,236 shares in the last quarter. Finally, Occidental Asset Management LLC grew its holdings in Agilent Technologies by 7.3% during the second quarter. Occidental Asset Management LLC now owns 27,263 shares of the medical research company's stock valued at $3,217,000 after purchasing an additional 1,847 shares during the period.

Agilent Technologies Stock Performance

Shares of NYSE:A opened at $128.21 on Wednesday. The firm has a fifty day simple moving average of $121.61 and a two-hundred day simple moving average of $116.02. Agilent Technologies, Inc. has a 52 week low of $96.43 and a 52 week high of $153.84. The company has a quick ratio of 1.71, a current ratio of 2.25 and a debt-to-equity ratio of 0.53. The stock has a market capitalization of $36.35 billion, a P/E ratio of 30.10, a PEG ratio of 4.04 and a beta of 1.24.

Agilent Technologies (NYSE:A - Get Free Report) last released its quarterly earnings results on Wednesday, August 27th. The medical research company reported $1.37 EPS for the quarter, hitting the consensus estimate of $1.37. Agilent Technologies had a return on equity of 25.51% and a net margin of 17.97%.The company had revenue of $1.74 billion during the quarter, compared to analyst estimates of $1.67 billion. During the same quarter last year, the business posted $1.32 earnings per share. The firm's revenue was up 10.1% on a year-over-year basis. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. On average, analysts expect that Agilent Technologies, Inc. will post 5.58 earnings per share for the current fiscal year.

Agilent Technologies Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, October 22nd. Investors of record on Tuesday, September 30th will be given a $0.248 dividend. The ex-dividend date is Tuesday, September 30th. This represents a $0.99 dividend on an annualized basis and a yield of 0.8%. Agilent Technologies's dividend payout ratio (DPR) is currently 23.24%.

Analysts Set New Price Targets

A number of research analysts recently issued reports on A shares. Evercore ISI cut their price objective on Agilent Technologies from $130.00 to $128.00 and set an "in-line" rating for the company in a research note on Thursday, August 28th. Wells Fargo & Company upped their price target on shares of Agilent Technologies from $140.00 to $150.00 and gave the stock an "overweight" rating in a research report on Monday, September 15th. Barclays restated an "equal weight" rating and set a $125.00 price objective on shares of Agilent Technologies in a research report on Friday, August 29th. Robert W. Baird upped their target price on shares of Agilent Technologies from $141.00 to $142.00 and gave the stock an "outperform" rating in a report on Thursday, August 28th. Finally, Wall Street Zen lowered Agilent Technologies from a "buy" rating to a "hold" rating in a research note on Friday, September 5th. Six analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company's stock. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $140.08.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.